| 
           Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
            The web pages are not kept up to date and are for demonstration purposes only. 
            For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. 
         | 
        BACK TO LIST | 
                     
  | 
                  
                     
 
  | 
                  
                     
 
  | 
               |||||||||||||||||||||||||
| Test | 20-SEP-2022 | Reference Range | Unit | 
|---|---|---|---|
| Hemoglobin A1c/Hemoglobin.total in Blood | 6.2 | 4.5 - 6.4 | % | 
| Glucose [Mass/volume] in Blood | 97.9 | 70 - 99 | mg/dL | 
| Urea nitrogen [Mass/volume] in Blood | 10.8 | 7 - 20 | mg/dL | 
| Creatinine [Mass/volume] in Blood | 0.8 L | 0.9 - 1.3 | mg/dL | 
| Calcium [Mass/volume] in Blood | 9.4 | 8.6 - 10.2 | mg/dL | 
| Sodium [Moles/volume] in Blood | 141.3 | 135 - 145 | mmol/L | 
| Potassium [Moles/volume] in Blood | 4.7 | 3.5 - 5.1 | mmol/L | 
| Chloride [Moles/volume] in Blood | 102.0 | 98 - 108 | mmol/L | 
| Carbon dioxide, total [Moles/volume] in Blood | 28.4 | 22 - 29 | mmol/L | 
| Cholesterol [Mass/volume] in Serum or Plasma | 144.8 | 0 - 200 | mg/dL | 
| Triglyceride [Mass/volume] in Serum or Plasma | 122.9 | 40 - 150 | mg/dL | 
| Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | 80.1 | 0 - 130 | mg/dL | 
| Cholesterol in HDL [Mass/volume] in Serum or Plasma | 40.2 | 40 - 100 | mg/dL | 
| Conclusion and Recommendations based on this report and previous findings known to us | 
|---|
| All measured parameters are within or close to normal ranges. HbA1c is at the upper limit, suggesting good but borderline glycemic control. Creatinine is slightly below normal but not clinically significant. Lipid profile is favorable, with LDL and triglycerides well controlled and HDL at the lower normal limit. No acute abnormalities detected. Recommend continued monitoring, especially of glycemic control. |